About
Services
Learning
Projects
News
AstraZeneca’s U.S. COVID-19 trial is back on track after 45-day hold
KSQ boosts PARP inhibition in animal models of ovarian and breast cancers with USP1 inhibitor
Ultragenyx dives into Duchenne with $40M Solid Bio deal
FDA cleared medium-risk medical devices that failed agency's own protocols: study
Alnylam makes case for lumasiran in infants ahead of FDA ruling
About
Services
Learning
Projects
News
